680
Participants
Start Date
January 12, 2015
Primary Completion Date
March 9, 2018
Study Completion Date
March 9, 2018
602, Brussels
604, Edegem
601, Genk
603, Heusy
53, Altenburg
18, Bayreuth
6, Bayreuth
13, Berlin
14, Berlin
16, Berlin
30, Berlin
7, Berlin
4, Burghausen
25, Chemnitz
50, Cottbus
11, Dresden
8, Düsseldorf
36, Elmshorn
35, Erfurt
19, Freiburg im Breisgau
41, Goslar
26, Greifswald
32, Halle
23, Hamburg
47, Hamburg
1, Hanover
44, Hanover
42, Heidelberg
10, Herne
40, Hofheim am Taunus
34, Hoyerswerda
27, Karlsruhe
48, Karlstadt am Main
49, Karlstadt am Main
21, Leipzig
38, Leipzig
9, Magdeburg
29, Marktredwitz
31, München
43, München
2, Naunhof
20, Planegg
24, Potsdam
15, Püttlingen
28, Saarbrücken
51, Wuppertal
39, Zwickau
202, Athens
210, Athens
211, Athens
212, Athens
207, Larissa
208, Marousi
201, Pátrai
203, Thessaloniki
204, Thessaloniki
205, Thessaloniki
206, Thessaloniki
504, Florence
501, Palermo
502, Potenza
505, Roma
500, Siena
503, Verona
116, Barcelona
114, Bilbao
122, Cartagena
108, Córdoba
118, Donostia / San Sebastian
120, Granada
107, León
123, Lorca
101, Mérida
119, Murcia
117, Salamanca
121, Sant Joan Despí
112, Tarragona
115, Terrassa
416, Barnsley
405, Basingstoke
401, Bath
423, Bolton
421, Christchurch
403, Hull
420, Leeds
415, Leicester
409, Liverpool
422, Llandudno
411, Luton
414, Manchester
406, Middlesbrough
424, North Shields
413, Norwich
410, Preston
412, Southampton
419, Stevenage
418, Sunderland
408, Torquay
407, Truro
425, Wigan
Collaborators (1)
Parexel
INDUSTRY
UCB Biopharma S.P.R.L.
INDUSTRY